Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro
- PMID: 32985597
- PMCID: PMC7522996
- DOI: 10.1038/s41598-020-73058-4
Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro
Abstract
Kava is a beverage made from the ground roots of the plant Piper Methysticum. Active compounds of Kava have previously been demonstrated to exert an antiproliferative effect through cell cycle arrest and promotion of apoptosis. Our aim was to investigate the in vitro effects of the main constituents derived from Kava on oral squamous cell carcinoma (OSCC) activity. Gas chromatography mass spectrometry (GCMS) was used to characterise the main constituents of two Kava preparations. Cell proliferation was assessed in two human OSCC cell lines (H400 and BICR56) and in normal oral keratinocytes (OKF6) treated with the identified Kava constituents, namely Flavokawain A (FKA), Flavokawain B (FKB), yangonin, kavain and methysticin using an MTS in vitro assay. Cell migration at 16 h was assessed using a Transwell migration assay. Cell invasion was measured at 22 h using a Matrigel assay. Cell adhesion was assessed at 90 min with a Cytoselect Adhesion assay. The two Kava preparations contained substantially different concentrations of the main chemical constituents. Treatment of malignant and normal oral keratinocyte cell lines with three of the identified constituents, 10 μg/ml FKA, 2.5 μg/ml FKB and 10 μg/ml yangonin, showed a significant reduction in cell proliferation in both H400 and BICR56 cancer cell lines but not in normal OKF6 cells. Remarkably, the same Kava constituents induced a significant reduction of OSCC cell migration and invasion. We have demonstrated, for the first time, that Kava constituents, FKA, FKB and yangonin have potential anticancer effects on OSCC. This highlights an avenue for further research of Kava constituents in the development of future cancer therapies to prevent and treat OSCC.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Protective effect of kava constituents in an in vitro model of oral mucositis.J Cancer Res Clin Oncol. 2020 Jul;146(7):1801-1811. doi: 10.1007/s00432-020-03253-3. Epub 2020 May 20. J Cancer Res Clin Oncol. 2020. PMID: 32435894
-
A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Piper methysticum (Kava).Molecules. 2019 Mar 30;24(7):1245. doi: 10.3390/molecules24071245. Molecules. 2019. PMID: 30934989 Free PMC article.
-
Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.Pharm Biol. 2016 Sep;54(9):1503-12. doi: 10.3109/13880209.2015.1107104. Epub 2016 Jan 20. Pharm Biol. 2016. PMID: 26789234 Free PMC article.
-
[Kava-kava preparations--alternative anxiolytics].Pol Merkur Lekarski. 1998 Mar;4(21):179-180a. Pol Merkur Lekarski. 1998. PMID: 9640076 Review. Polish.
-
Analysis of kavalactones from Piper methysticum (kava-kava).J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 5;812(1-2):203-14. doi: 10.1016/j.jchromb.2004.07.038. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15556499 Review.
Cited by
-
Flavonoids with Anti-Angiogenesis Function in Cancer.Molecules. 2024 Mar 31;29(7):1570. doi: 10.3390/molecules29071570. Molecules. 2024. PMID: 38611849 Free PMC article. Review.
References
-
- Lebot VMM, Lindstrom LC. Kava: The Pacific Drug. Yale: Yale University Press; 1992.
-
- WHO, F. A. A. O. O. t. U. N. Kava: a review of the safety of traditional and recreational beverage consumption (2016).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources